APN LSE Week ended 24 Jul 2026

Weekly Investor Report

Name: APN weekly investor report
Creator: Sharemaestro
License: https://sharemaestro.com/data-license/

Applied Nutrition Plc · Consumer Defensive · Packaged Foods

Open interactive chart View report data

Latest close 334.5 GBP

1.2% latest week

Weekly setup

Constructive, but selective

The weekly trend is active. Price is 32.4% above the Trend Line and sits at 97.4% of its 52-week range. The latest completed week returned 1.2%, after a 8.1% four-week move. The latest factor snapshot indicates quality ranks strongly versus its universe; growth ranks strongly; valuation is expensive relative to peers. The latest news-sentiment score is 54/100. Near-term considerations: price is close to its 52-week high.

Setup score 72 out of 100

Latest Close 334.5 GBP 24 Jul 2026

1W Return 1.2% latest completed week

4W Return 8.1% short-term follow-through

12W Return 54.9% quarterly tape

Trend Breadth 84.6% 44 of 52 weeks active

Volume Ratio 1.0x vs 13-week average

What is working

The trend backdrop is active with a 8-week active streak.
Price is above the Trend Line, keeping the weekly tape constructive.
Price is above Fair Value, showing premium demand versus the model.
Activity pressure is positive on the latest completed week.

What could go wrong

12 reversal markers appear in the recent smart-money tape.

What to watch next

Price is close to its 52-week high; watch for continuation or exhaustion.
Trend Line remains the key weekly regime level.
Activity pressure is the gauge to monitor for confirmation or fade.
A volume ratio above 1.5x would show stronger participation in the next move.

Price follow-through 1.2% Latest completed week; four-week move 8.1%. Indicator stack 74/71 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Positive 58.58% Historical one-week expectancy contributes to the evidence score when direction is confirmed. News sentiment 54/100 13 relevant articles in the latest sentiment read.

01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 32.4% above the Trend Line and sits at 97.4% of its 52-week range. The latest completed week returned 1.2%, after a 8.1% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value

Price Trend Line Fair Value

Position in the 52-week range

Close Trend Fair

128.0 GBP 97.4% 340.0 GBP

Range location97.4%Shows where the latest close sits between the 52-week low and high.

Trend distance32.4%Price premium or discount versus the weekly Trend Line.

Fair-value gap84.1%Premium demand or model discount versus Sharemaestro Fair Value.

High-water gap-1.6%Distance from the latest 52-week high.

02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.0x the 13-week average. Participation is around or above normal and provides reasonable confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction

30 Jan 6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul

Up week Down week

Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.7412-week average 0.50

12-week confirmation

Trend active8/12Active trend-backdrop weeks in the latest 12-week window.

Positive pressure7/12Weeks with constructive activity pressure in the latest 12-week window.

Positive leadership12/12Weeks with positive relative leadership in the latest 12-week window.

Activity pressure0.74Current proprietary activity-pressure read.

Buy signals0Accumulation signal count in the latest 12 weeks.

Reversal markers1212 reversal markers

No recent accumulation markers. 12 reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 8.1% over four weeks, 54.9% over 12 weeks, and 153.0% over one year. The current trend has remained active for 8 consecutive weeks.

Performance by holding period

1W1.2%

4W8.1%

12W54.9%

26W39.4%

52W153.0%

Active trend streak8 weeks

Active weeks in one year44

Trend breadth84.6%

Activity pressure vs relative leadership

Activity pressureRelative leadership

Pressure1.12Latest activity-pressure read.

Pressure change15.0%Four-week change in activity pressure.

Leadership42.29Latest relative-leadership reading.

RS change-1.1%Four-week change in relative leadership.

04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks strongly versus its universe; growth ranks strongly; valuation is expensive relative to peers.

Open full factor analysis

Factor week 26 Jul 2026 Financial statements through 31 Jul 2025 Field coverage 91% Model confidence 79%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength44/100Blend of value, momentum, and quality. Underlying universe rank 57; rank 1 is best.

Value1/100Relative valuation strength. Underlying universe rank 100; rank 1 is best.

Quality87/100Profitability and accounting quality. Underlying universe rank 14; rank 1 is best.

Momentum100/100Medium-term price momentum. Underlying universe rank 1; rank 1 is best.

Growth91/100Revenue and earnings growth. Underlying universe rank 10; rank 1 is best.

How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework25/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E: 39.6x
Price / sales: 7.8x
EV / EBITDA: 27.4x
Free-cash-flow yield: 1.8%

Business quality

Margins and the return generated on invested capital.

Gross margin: 46.0%
Operating margin: 26.2%
Free-cash-flow margin: 13.6%
Return on invested capital: 45.5%

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth: 24.2%
EPS growth: 12.8%
Free-cash-flow growth: 156.1%
Piotroski F-score: 3/9

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield: 1.8%
Buyback yield: 0.0%
Shareholder yield: 1.8%
Net debt / EBITDA: -0.8x

05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment54/100

Weighted news tone is neutral across 13 relevant articles.

4 positive · 8 neutral · 1 negative

Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal

06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings-No event is currently stored.

Options expected move-Nearest-chain priced movement where available.

52-week drawdown-1.6%Distance below the 52-week high.

13-week volatility4.6%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

30 Jan 27 Feb 27 Mar 24 Apr 22 May 19 Jun 24 Jul

Weeks higher16 of 2610 weeks finished lower.

Best week+14.6%Week of 5 Jun.

Worst week-5.5%Week of 13 Mar.

Latest week+1.2%Week of 24 Jul.

Shape of recent returns

Strong gains6

Modest gains10

Flat weeks0

Modest losses6

Sharp losses4

Recent vol4.6%13-week weekly-return volatility.

Base vol6.0%52-week weekly-return volatility.

Up/down split31/18Count of positive and negative weeks in the 52-week window.

Average skew5.1% / -3.1%Average positive week versus average negative week.

07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

SectorGB Consumer Defensive

4-week rank6 / 58

Group average0.3%

Trend breadth44.8%

Trend44.8%active weekly trend signals

MD58.6%positive activity pressure

RS27.6%positive relative leadership

Four-week leaders

GNC · LSE19.5%MPE · LSE13.2%AEP · LSE11.6%ANP · LSE10.5%SBRY · LSE9.4%

IndustryGB Packaged Foods

4-week rank3 / 17

Group average-0.9%

Trend breadth64.7%

Trend64.7%active weekly trend signals

MD58.8%positive activity pressure

RS23.5%positive relative leadership

Four-week leaders

GNC · LSE19.5%ANP · LSE10.5%APN · LSE8.1%FVA · LSE4.8%HFG · LSE3.7%

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape69/100

Trend, activity pressure, participation, and risk combine to a 69/100 tape read.

Indicator analysis61/100

Latest 12-week confirmation: trend 8/12, activity pressure 7/12, relative leadership 12/12.

Activity pressure 0.74; 12 reversal markers Next-Week ExpectancyPositive 58.58%

Next-week expectancy is positive with a 58.58% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors56/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 71; Small Cap Core rank 99 SVQF25/100

Value and quality alignment from the Sharemaestro SVQF framework.

Composite rank 190.0 of 254 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment54/100

Weighted news tone is neutral across 13 relevant articles.

CFO & Director Of Applied Nutrition Sold 46% Of Their Shares Insiders50/100

No recent insider transaction evidence is stored.

Earnings50/100

No stored earnings event is currently attached to this ticker.

Week	Close	Return	Trend Line	Fair Value	Pressure	Leadership	Volume	Trend
24 Jul 2026	334.5 GBP	1.2%	252.6 GBP	181.7 GBP	1.12	42.29	1.5M	On
17 Jul 2026	330.5 GBP	2.2%	249.9 GBP	180.0 GBP	1.11	44.51	2.5M	On
10 Jul 2026	323.5 GBP	2.5%	247.4 GBP	178.4 GBP	1.09	45.03	1.9M	On
3 Jul 2026	315.5 GBP	1.9%	244.4 GBP	176.7 GBP	1.07	41.17	1.8M	On
26 Jun 2026	309.5 GBP	6.4%	240.6 GBP	175.2 GBP	0.97	42.75	1.5M	On
19 Jun 2026	291.0 GBP	-0.9%	236.2 GBP	173.6 GBP	0.66	38.05	1.5M	On
12 Jun 2026	293.5 GBP	5.2%	232.4 GBP	172.3 GBP	0.31	39.59	421.3K	On
5 Jun 2026	279.0 GBP	14.6%	228.2 GBP	170.8 GBP	-0.14	35.83	164.7K	On
29 May 2026	243.5 GBP	6.3%	225.0 GBP	169.5 GBP	-0.52	19.54	873.0K	Off
22 May 2026	229.0 GBP	8.5%	222.6 GBP	168.7 GBP	-0.71	12.75	2.2M	Off
15 May 2026	211.0 GBP	-2.8%	220.9 GBP	167.9 GBP	-0.83	7.41	2.5M	Off
8 May 2026	217.0 GBP	0.5%	219.8 GBP	167.4 GBP	-0.75	10.82	1.8M	Off
1 May 2026	216.0 GBP	-2.0%	218.6 GBP	166.8 GBP	-0.78	9.71	1.3M	On
24 Apr 2026	220.5 GBP	1.4%	216.8 GBP	166.1 GBP	-0.82	12.62	1.3M	On

How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.